Schisandra
Schisandra berry products marketed for stress, exercise, liver, or cognitive claims. Available evidence is largely network, cell, animal, or interaction-focused rather than replicated clinical efficacy in humans.
Pharmacokinetic model
A route-level PK model for schisandra is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Herb
- Suggested cadence
- once daily
Research behind this entry
-
Systematic analysis of the pharmacological function of Schisandra as a potential exercise supplement
Network-pharmacology analysis selected predicted compounds and targets using database drug-likeness and bioavailability filters. It did not test exercise performance in a randomized human trial and should be treated as…
-
Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance
Broad interaction review includes Schisandra among many natural products and describes mechanistic concerns relevant to cancer treatment. It is contextual safety evidence, not proof of therapeutic benefit.
2 published studies referenced in the app, each with a plain-language summary.